Real-world impact of transitioning from one lipoprotein(a) assay to another in a clinical setting

Background and aims: Different lipoprotein(a) [Lp(a)] assays may affect risk stratification of individuals and thus clinical decision-making. We aimed to investigate how transitioning between Lp(a) assays at a large central laboratory affected the proportion of individuals with Lp(a) result above cl...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Janeni Jeevanathan, Sigrid M. Blom, Thomas Olsen, Kirsten B. Holven, Erik K. Arnesen, Torleif Trydal, Børge G. Nordestgaard, Michael Sovershaev, Ying Chen, Kjetil Retterstøl, Jacob J. Christensen
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Elsevier 2024-09-01
Saila:	American Journal of Preventive Cardiology
Gaiak:	Lipids Lipoprotein(a) Lipoprotein(a) assay
Sarrera elektronikoa:	http://www.sciencedirect.com/science/article/pii/S2666667724000941
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!